摘要
预混胰岛素50制剂针对中国糖尿病患者胰岛素早相分泌不足的特点,近年来临床使用率不断提高。中国专家基于预混胰岛素50制剂的有效性与安全性证据及临床使用经验,制订了《预混胰岛素50制剂临床应用专家指导意见》,重点阐述预混胰岛素50制剂的适用人群、起始、转换及剂量调整方案供临床参考。
In recent years,the clinical use rate of premixed insulin 50 has been increasing because it accord to the hyposecretion of early phase of insulin in Chinese diabetics.Based on the evidence of effectiveness and safety of premixed insulin 50 and clinical experience,Chinese experts formulated the Practical Guidance on the Use of Premixed insulin 50 on Clinical Applications,focusing on the suitable population,initiation,conversion and dosage adjustment plan of premixed insulin 50 for clinical reference.
出处
《药品评价》
CAS
2019年第21期1-3,共3页
Drug Evaluation